Gelonghui October 23rd | Chuaning Biology (301301.SZ) stated at the investor relations event that as of September, the PHA project has completed small-scale and mid-scale process validation. The fermentation level has reached expectations, even exceeded them; the product cost is expected to reach a lower level within the same industry after full-scale production, and the company is also considering planning in Kazakhstan, where agricultural product costs are lower, to reduce production costs and further open up the international market.